JP5866126B2 - 骨格筋量および神経性状態のマーカーとしてのｂｉｎ１発現 - Google Patents

骨格筋量および神経性状態のマーカーとしてのｂｉｎ１発現 Download PDF

Info

Publication number
JP5866126B2
JP5866126B2 JP2013538809A JP2013538809A JP5866126B2 JP 5866126 B2 JP5866126 B2 JP 5866126B2 JP 2013538809 A JP2013538809 A JP 2013538809A JP 2013538809 A JP2013538809 A JP 2013538809A JP 5866126 B2 JP5866126 B2 JP 5866126B2
Authority
JP
Japan
Prior art keywords
bin1
subject
level
skeletal muscle
muscle mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013538809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014500960A (ja
JP2014500960A5 (https=
Inventor
ダリル スティーブン ショー，
ダリル スティーブン ショー，
ニール ゲイビン ショー，
ニール ゲイビン ショー，
Original Assignee
サーコーティン ダイアグノスティックス エルエルシー
サーコーティン ダイアグノスティックス エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サーコーティン ダイアグノスティックス エルエルシー, サーコーティン ダイアグノスティックス エルエルシー filed Critical サーコーティン ダイアグノスティックス エルエルシー
Publication of JP2014500960A publication Critical patent/JP2014500960A/ja
Publication of JP2014500960A5 publication Critical patent/JP2014500960A5/ja
Application granted granted Critical
Publication of JP5866126B2 publication Critical patent/JP5866126B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013538809A 2010-11-09 2011-11-07 骨格筋量および神経性状態のマーカーとしてのｂｉｎ１発現 Active JP5866126B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41168310P 2010-11-09 2010-11-09
US61/411,683 2010-11-09
PCT/US2011/059574 WO2012087437A2 (en) 2010-11-09 2011-11-07 Bin1 expression as a marker of skeletal muscle mass and neurological conditions

Publications (3)

Publication Number Publication Date
JP2014500960A JP2014500960A (ja) 2014-01-16
JP2014500960A5 JP2014500960A5 (https=) 2014-12-25
JP5866126B2 true JP5866126B2 (ja) 2016-02-17

Family

ID=46314702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013538809A Active JP5866126B2 (ja) 2010-11-09 2011-11-07 骨格筋量および神経性状態のマーカーとしてのｂｉｎ１発現

Country Status (6)

Country Link
US (1) US9891232B2 (https=)
EP (1) EP2638403B1 (https=)
JP (1) JP5866126B2 (https=)
AU (2) AU2011345312A1 (https=)
CA (1) CA2817519C (https=)
WO (1) WO2012087437A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010124240A2 (en) 2009-04-24 2010-10-28 The Regents Of The University Of California Bin1 as a prognostic marker in cardiovascular disease
US8999659B2 (en) 2010-10-20 2015-04-07 The Regents Of The University Of California Body fluid BIN1 as a marker of cardiac health
US9846159B2 (en) 2011-09-30 2017-12-19 Sarcotein Diagnostics, Llc BIN1 expression as a marker of cancer
WO2016141088A1 (en) 2015-03-02 2016-09-09 Sarcotein Diagnostics, Llc 13+/17+ bin1 expression as a marker of cardiac disorders
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
JP6886241B2 (ja) * 2016-01-07 2021-06-16 味の素株式会社 骨格筋面積の評価方法
MY198194A (en) * 2016-05-02 2023-08-09 Prothena Biosciences Ltd Antibodies Recognizing Tau
US12054543B2 (en) 2018-07-25 2024-08-06 Accurus Biosciences, Inc. CLDN 18.2-specific monoclonal antibodies and methods of use thereof
CA3115077A1 (en) * 2018-10-09 2020-04-16 Ibex Biosciences, Llc Antibodies directed to filamin-a and therapeutic uses thereof
WO2022132859A1 (en) * 2020-12-15 2022-06-23 Arizona Board Of Regents On Behalf Of Arizona State University Antibodies specific for qsox1 and methods of using the same
CN112778414B (zh) * 2020-12-31 2022-04-15 中南大学湘雅二医院 cBIN1抗体及其应用
CN112794900B (zh) * 2020-12-31 2022-10-25 中南大学湘雅二医院 cBIN1抗体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048702A (en) * 1995-05-05 2000-04-11 The Wistar Institute Of Anatomy And Biology Murine and human box-dependent myc-interacting protein (Bin1) and uses therefor
WO2001004354A2 (en) 1999-07-07 2001-01-18 Regeneron Pharmaceuticals, Inc. Use of ras inhibitors of inhibiting muscle atrophy
US6831063B1 (en) * 1999-08-31 2004-12-14 The Wistar Institute Of Anatomy And Biology Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor
US20090088482A1 (en) * 2003-10-14 2009-04-02 The Trustees Of Columbia University In The City New York Compositions and Methods For Treating Heart Failure
ES2367311T3 (es) * 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
WO2006009629A2 (en) * 2004-06-10 2006-01-26 New York University Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same
US20100086481A1 (en) 2006-07-11 2010-04-08 Baird Alison E Differential expression of molecules associated with intra-cerebral hemorrhage
WO2010124240A2 (en) 2009-04-24 2010-10-28 The Regents Of The University Of California Bin1 as a prognostic marker in cardiovascular disease
US8999659B2 (en) * 2010-10-20 2015-04-07 The Regents Of The University Of California Body fluid BIN1 as a marker of cardiac health

Also Published As

Publication number Publication date
CA2817519A1 (en) 2012-06-28
JP2014500960A (ja) 2014-01-16
US20130324432A1 (en) 2013-12-05
WO2012087437A2 (en) 2012-06-28
US9891232B2 (en) 2018-02-13
EP2638403A2 (en) 2013-09-18
EP2638403B1 (en) 2017-03-22
AU2017201661A1 (en) 2017-03-30
AU2017201661B2 (en) 2019-01-17
EP2638403A4 (en) 2014-05-07
WO2012087437A3 (en) 2012-08-16
AU2011345312A1 (en) 2013-06-20
CA2817519C (en) 2020-01-14

Similar Documents

Publication Publication Date Title
JP5866126B2 (ja) 骨格筋量および神経性状態のマーカーとしてのｂｉｎ１発現
CN110720041B (zh) 用心肌肌钙蛋白i和早期生物标记物帮助诊断和评价人受试者中轻度创伤性脑损伤的方法
JP7437303B2 (ja) 外傷性脳損傷を診断及び査定するための、新規のバイオマーカー及び方法
KR20100135892A (ko) 면역 관련 질병의 치료를 위한 신규한 조성물 및 방법
KR20200140400A (ko) 집락 자극 인자 1 수용체(csf1r)에 결합하는 항체로 질환을 치료하는 방법
US10767227B2 (en) Compositions and methods for determining genetic polymorphisms in the TMEM216 gene
US8906864B2 (en) Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
May et al. Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders
US20080107600A1 (en) Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same
EP3244911A1 (en) Antibodies, compounds and derivatives thereof for use in the treatment of male infertility
JP2018188394A (ja) リン酸化Ｓｍｕｒｆ２を認識する抗体、該抗体を含む癌の診断剤、並びに該抗体を使用した癌の治療剤のスクリーニング方法
JP2013039111A (ja) スプライシングバリアント
US20100022404A1 (en) Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
US6680172B1 (en) Treatments and markers for cancers of the central nervous system
JP2018522947A (ja) 非アルコール性脂肪肝調節因子１４−３−３タンパク質
EP3133400B1 (en) Use of ak6 and gpx5 male fertility related proteins or combination thereof
US7776538B2 (en) Method for diagnosing methamphetamine dependence
CN110499365A (zh) Agap9在制备诊断骨关节炎的产品中的应用
WO2026052672A1 (en) Comp cleavage peptide and its use in diagnosis of osteoarthritis
CA2532553A1 (en) Methods for identifying compounds for regulating muscle mass or function using dopamine receptors
KR101849685B1 (ko) 샤르코-마리-투스병 제1형의 원인 유전자로서 ｐｍｐ２２ 및 이를 이용한 상기 질병의 진단방법
US9638699B2 (en) Biomarkers of oxidative stress
HK1242740A1 (en) Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
JPWO2004016783A1 (ja) アトピー性皮膚炎の検査方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141106

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150729

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151023

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151130

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151230

R150 Certificate of patent or registration of utility model

Ref document number: 5866126

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250